Fig. 2.
Recurrence time and survival time in different groups. PEOC: primary epithelial ovarian cancer; NSCLC: non-small cell lung cancer; MDR1: multidrug resistance 1; MDR1+: MDR1 positive group; MDR1-: MDR1 negative group.
Recurrence time and survival time in different groups. PEOC: primary epithelial ovarian cancer; NSCLC: non-small cell lung cancer; MDR1: multidrug resistance 1; MDR1+: MDR1 positive group; MDR1-: MDR1 negative group.